Skip to main content

Table 4 Analysis of factors significantly associated with height gain after treatment

From: Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study

Height Gain After Treatmentb

Univariate Analysis

Correlation Coefficient

P-value

At the start of therapy

   

CA (yr)

-0.58

0.0005

BA (yr)

-0.73

<.0001

BA minus CA

-0.62

0.0001

Peak FSH

0.38

0.0344

Growth rate

0.44

0.0151

During therapy

   

Duration of the treatment

0.39

0.0292

Averaged growth rate

0.58

0.0006

ΔBA/ΔCA

0.54

0.0015

Basal FSH

-0.36

0.0447

At the end of therapy

   

BA

-0.63

0.0001

Multiple Linear Regression

Beta Coefficient

P-value

R 2

BA at baseline

-3.08

<0.0001

 

Duration of treatment

-1.87

0.0002

0.72

  1. aFinal adult height minus height at the end of treatment